Companies: 10,795·Total market cap: $144.5T
60 Degrees Pharmaceuticals, Inc.

60 Degrees Pharmaceuticals, Inc.

SXTPNASDAQHealthcare● Active
$1.43
+$0.00(+0.00%)
Market Cap$1153367
P/E Ratio
52W High$11.84
52W Low$1.29
Overview

60 Degrees Pharmaceuticals, Inc. (SXTP) Insider Trading

Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.

SEC EDGAR · FMP · SXTP · as of Jun 9, 2026

Activity summary

Buy transactions

5

P-Purchase only

Sell transactions

0

12 Months

Buy/Sell ratio

Buy/Sell (by trades)

Overall sentiment

BULLISH
↑ Buy 100%Active transactions only · RSU vesting excluded0% Sell ↓

60 Degrees Pharmaceuticals, Inc. insiders have been net buyers of shares over the past 12 Months, which may signal confidence in the company's outlook.

Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only

As of Jun 9, 2026

SXTP insider buying and selling by quarter

SXTP insider selling · SXTP insider buying stocks · quarterly insider activity

Total insider buying (incl. awards)Total insider selling
631K315K0
2025 Q1
2025 Q2
2025 Q3
2025 Q4

Mobile shows last 4Q · Desktop shows full 8Q

Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters

As of Jun 9, 2026

Active insiders

Most active in past 12 months · SXTP ceo insider trading

Showing all insiders · Click a card to filter the transactions table below

Aggregated from reportingName · top 5 by trade count (12M) · no extra API

Recent insider transactions

SXTP executive sell shares · SXTP board member insider trading · SXTP insider trading SEC filing

Showing 24 most recent · Common Stock · Form 4 only

Scroll horizontally to see all columns

DOW GEOFFREY S

President and CEO · Director

Purchase

Date

Dec 15

Shares

9,670

Price

$0.80

Value

$8K

View Form 4 on SEC.gov

DOW GEOFFREY S

President and CEO · Director

Purchase

Date

Dec 11

Shares

3,613

Price

$0.92

Value

$3K

View Form 4 on SEC.gov

DOW GEOFFREY S

President and CEO · Director

Purchase

Date

Dec 10

Shares

9,350

Price

$0.95

Value

$9K

View Form 4 on SEC.gov

DOW GEOFFREY S

President and CEO · Director

Award

Date

Sep 12

Shares

7,201

Price

$1.39

Value

$10K

View Form 4 on SEC.gov

Landon Kristen

COO

Award

Date

Jan 17

Shares

4,540

Price

Value

View Form 4 on SEC.gov

DOW GEOFFREY S

President and CEO · Director

Award

Date

Jun 9

Shares

4,376

Price

$2.99

Value

$13K

View Form 4 on SEC.gov

XU CHERYL

Director

Purchase

Date

Jun 3

Shares

2,000

Price

$2.90

Value

$6K

View Form 4 on SEC.gov

XU CHERYL

Director

Purchase

Date

Jun 3

Shares

3,000

Price

$2.87

Value

$9K

View Form 4 on SEC.gov

DOW GEOFFREY S

President and CEO · Director

Award

Date

Jan 17

Shares

14,394

Price

Value

View Form 4 on SEC.gov

MILLER TYRONE

CFO

Award

Date

Jan 17

Shares

11,626

Price

Value

View Form 4 on SEC.gov

XU CHERYL

Director

Purchase

Date

Dec 16

Shares

2,000

Price

$1.45

Value

$3K

View Form 4 on SEC.gov

XU CHERYL

Director

Purchase

Date

Dec 13

Shares

1,500

Price

$1.52

Value

$2K

View Form 4 on SEC.gov

XU CHERYL

Director

Purchase

Date

Dec 13

Shares

1,500

Price

$1.55

Value

$2K

View Form 4 on SEC.gov

XU CHERYL

Director

Purchase

Date

Dec 13

Shares

1,500

Price

$1.58

Value

$2K

View Form 4 on SEC.gov

XU CHERYL

Director

Purchase

Date

Dec 13

Shares

1,500

Price

$1.60

Value

$2K

View Form 4 on SEC.gov

XU CHERYL

Director

Purchase

Date

Dec 12

Shares

2,500

Price

$1.80

Value

$5K

View Form 4 on SEC.gov

XU CHERYL

Director

Purchase

Date

Dec 12

Shares

2,500

Price

$1.85

Value

$5K

View Form 4 on SEC.gov

DOW GEOFFREY S

President and CEO · Director

Purchase

Date

Dec 9

Shares

35,823

Price

$1.27

Value

$46K

View Form 4 on SEC.gov

DOW GEOFFREY S

President and CEO · Director

Purchase

Date

Dec 6

Shares

20,579

Price

$1.20

Value

$25K

View Form 4 on SEC.gov

DOW GEOFFREY S

President and CEO · Director

Purchase

Date

Dec 5

Shares

17,549

Price

$1.11

Value

$20K

View Form 4 on SEC.gov

DOW GEOFFREY S

President and CEO · Director

Purchase

Date

Nov 21

Shares

3,500

Price

$0.91

Value

$3K

View Form 4 on SEC.gov

DOW GEOFFREY S

President and CEO · Director

Purchase

Date

Nov 20

Shares

1,000

Price

$0.92

Value

$924

View Form 4 on SEC.gov

DOW GEOFFREY S

President and CEO · Director

Purchase

Date

Nov 19

Shares

2,500

Price

$0.90

Value

$2K

View Form 4 on SEC.gov

XU CHERYL

Director

Purchase

Date

Aug 27

Shares

5,000

Price

$1.70

Value

$9K

View Form 4 on SEC.gov

Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —

About SXTP insider trading

SXTP insider trades

60 Degrees Pharmaceuticals, Inc. (SXTP) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including DOW GEOFFREY S (President and CEO · Director). Over the past 12 months, 1 insiders have filed transactions with the SEC. SXTP insiders have been primarily buying, which may reflect pre-scheduled Rule 10b5-1 plan executions.

For 60 Degrees Pharmaceuticals, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →

Buy/Sell signal logic
acquisitionOrDisposition field:
A = Acquisition (buy) · D = Disposition (sell)
RSU vesting (M-Exempt) excluded from sentiment
Form 4SEC filing required within 2 business days of any insider transaction
10b5-1Pre-scheduled trading plan that allows insiders to sell on autopilot
Open MktDirect purchase or sale on the open market (excludes awards, options)

Frequently asked questions

SXTP insider trading · 5 questions

The insiders of 60 Degrees Pharmaceuticals, Inc. (SXTP) include executives and directors such as DOW GEOFFREY S (President and CEO · Director), among others. Over the past 12 months, 1 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.

SXTP board member insider tradingwho are SXTP insidersSXTP insider roster60 Degrees Pharmaceuticals, Inc. executives insider activity

Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026